RightFit Trial Directory

Crohn's Disease clinical trials in Fort Worth, TX

9 recruiting crohn's disease studies with a site in Fort Worth, TX.

All trials in Fort Worth, TX · All Crohn's Disease trials

RecruitingPhase 2NCT07683325

NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease

Sponsor: Agomab Spain S.L.U.

Fort Worth, TX · Georgetown, TX · +3 more sites

RecruitingPhase 2NCT07697456

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Sponsor: AbbVie

Bellaire, TX · Fort Worth, TX · Garland, TX · +57 more sites

RecruitingPhase 3NCT04844606

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Sponsor: Eli Lilly and Company

Fort Worth, TX · +10 more sites

RecruitingPhase 3NCT05509777

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Sponsor: Eli Lilly and Company

Fort Worth, TX · +14 more sites

RecruitingPhase 1NCT03816345

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Sponsor: National Cancer Institute (NCI)

Dallas, TX · Fort Worth, TX · +48 more sites

RecruitingPhase 3NCT06819891

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Hoffmann-La Roche

Dallas, TX · Fort Worth, TX · Garland, TX · +58 more sites

RecruitingPhase 3NCT05923073

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Janssen Research & Development, LLC

Fort Worth, TX · +13 more sites

RecruitingPhase 2NCT06233461

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Takeda

Bellaire, TX · Dallas, TX · Fort Worth, TX · +27 more sites

RecruitingPhase 3NCT06663332

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Sponsor: Janssen Research & Development, LLC

Fort Worth, TX · +5 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.